跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Clindasaph
Approved
STANDARD
Clindasaph
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3e9fb5c3848cfbea
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
3e9fb5c3848cfbea
Drug Approval Philippines Name
Clindasaph
Product Name
Clindasaph
Registration Number
DRP-13684
Brand Name
Clindasaph
Generic Name
Clindamycin (as hydrochloride)
Dosage Form
Capsule
Dosage Strength
150 mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
29 May 2024
Expiry Date
28 March 2028
Pharmacologic Category
Antibacterial (Lincosamide)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3e9fb5c3848cfbea
Type
Standard
Back to Philippines FDA Approvals
Clindasaph - Philippines FDA Drug Approval Details